BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28572614)

  • 1. Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study.
    Hong YJ; Park HS; Park JK; Han K; Park CH; Kim TK; Yoo SJ; Lee JY; Kim PK; Hur J; Lee HJ; Kim YJ; Suh YJ; Paek MY; Choi BW
    Sci Rep; 2017 Jun; 7(1):2663. PubMed ID: 28572614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping and Histology in a Rabbit Model.
    Hong YJ; Kim TK; Hong D; Park CH; Yoo SJ; Wickum ME; Hur J; Lee HJ; Kim YJ; Suh YJ; Greiser A; Paek MY; Choi BW
    JACC Cardiovasc Imaging; 2016 Jul; 9(7):836-845. PubMed ID: 27236517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
    Galán-Arriola C; Lobo M; Vílchez-Tschischke JP; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Agüero J; Fernández-Jiménez R; Martín-García A; Oliver E; Villena-Gutierrez R; Pizarro G; Sánchez PL; Fuster V; Sánchez-González J; Ibanez B
    J Am Coll Cardiol; 2019 Feb; 73(7):779-791. PubMed ID: 30784671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of anthracycline-induced myocardial injury using serial cardiac magnetic resonance: An animal study.
    Wang R; Zhou Z; Schoepf UJ; Varga-Szemes A; Strigenz A; Wang H; Liu Y; Xu L
    Int J Cardiol; 2021 Apr; 328():111-116. PubMed ID: 33359332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
    Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity.
    Nakata K; Kucukseymen S; Cai X; Yankama T; Rodriguez J; Sai E; Pierce P; Ngo L; Nakamori S; Tung N; Manning WJ; Nezafat R
    J Cardiovasc Magn Reson; 2024 Summer; 26(1):101033. PubMed ID: 38460840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
    Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial T1 mapping of right ventricle in pulmonary hypertension: comparison with histology in an animal study.
    Kim PK; Hong YJ; Shim HS; Im DJ; Suh YJ; Lee KH; Hur J; Kim YJ; Choi BW; Lee HJ
    J Cardiovasc Magn Reson; 2021 May; 23(1):64. PubMed ID: 34039372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac MRI Myocardial Functional and Tissue Characterization Detects Early Cardiac Dysfunction in a Mouse Model of Chemotherapy-Induced Cardiotoxicity.
    Naresh NK; Misener S; Zhang Z; Yang C; Ruh A; Bertolino N; Epstein FH; Collins JD; Markl M; Procissi D; Carr JC; Allen BA
    NMR Biomed; 2020 Sep; 33(9):e4327. PubMed ID: 32567177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying early stages of doxorubicin-induced cardiotoxicity in rat model by 7.0 tesla cardiovascular magnetic resonance combining hematological and pathological parameters.
    Wang S; Zhu T; Wang C; Wang L; He B; Gao F
    Magn Reson Imaging; 2022 Jul; 90():17-25. PubMed ID: 35122985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of doxorubicin-induced interstitial myocardial fibrosis in a beagle model using equilibrium contrast-enhanced computed tomography: A comparative study with cardiac magnetic resonance T1-mapping.
    Zhou Z; Xu L; Wang R; Varga-Szemes A; Durden JA; Joseph Schoepf U; Sun Z; Fan Z
    Int J Cardiol; 2019 Apr; 281():150-155. PubMed ID: 30738608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-parameter cardiac magnetic resonance imaging detects anthracycline-induced cardiotoxicity in rabbits model.
    Hu Y; Ma P; Chen L; Liu J; Shang Y; Jian W
    Heliyon; 2023 Nov; 9(11):e21845. PubMed ID: 38058655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction.
    Al-Wakeel-Marquard N; Rastin S; Muench F; O H-Ici D; Yilmaz S; Berger F; Kuehne T; Messroghli DR
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1961-1968. PubMed ID: 28620681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance parametric techniques to characterize myocardial effects of anthracycline therapy in adults with normal left ventricular ejection fraction: a systematic review and meta-analysis.
    Musella F; Librera M; Sibilio G; Boccalatte M; Tagliamonte G; Cavaglià E; Ferrara I; Puglia M; Dell'Aversana S; Ducci CB; Dellegrottaglie S; Savarese G; Scatteia A
    Curr Probl Cardiol; 2024 Jul; 49(7):102609. PubMed ID: 38697332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological validation of cardiac magnetic resonance T
    Zeng M; Zhang N; He Y; Wen Z; Wang Z; Zhao Y; Greiser A; An J; Zhang T; Jing B; Zhang X; Fan Z; Li D
    J Magn Reson Imaging; 2016 Nov; 44(5):1179-1185. PubMed ID: 27061226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.
    Jordan JH; Vasu S; Morgan TM; D'Agostino RB; Meléndez GC; Hamilton CA; Arai AE; Liu S; Liu CY; Lima JA; Bluemke DA; Burke GL; Hundley WG
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27502058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular volume quantification by cardiac magnetic resonance imaging without hematocrit sampling : Ready for prime time?
    Kammerlander AA; Duca F; Binder C; Aschauer S; Zotter-Tufaro C; Koschutnik M; Marzluf BA; Bonderman D; Mascherbauer J
    Wien Klin Wochenschr; 2018 Mar; 130(5-6):190-196. PubMed ID: 28980127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of early anthracycline-induced cardiotoxicity and liver injury with T2 and T2* mapping in rabbit models.
    Feng XL; Qi WY; Xiao ZY; Zheng X; Zhang XY; Liu T; Kou XY; Chen J
    Eur Radiol; 2024 Jan; 34(1):226-235. PubMed ID: 37552260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.